Work

Access to positron emission tomography combined with computed tomography in the management of lung cancer in Te Manawa Taki Midland Region of New Zealand

Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: This study examines access to 18-F fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT; PET-CT) scans among lung cancer patients. DATA AND METHODS: Patients diagnosed with lung cancer in 2011-2021 were identified from the Midland Lung Cancer Register and the New Zealand Cancer Registry. Patients were linked to the National Non-Admitted Patient Collection to determine if they underwent PET-CT. Logistic regression was used to estimate the odds ratios of having PET-CT, adjusting for age, gender, ethnicity, year of diagnosis, socio-economic status, cancer stage, cell type, Eastern Cooperative Oncology Group (ECOG) status and comorbidities. RESULTS: We identified 613 patients with stage I, 300 with stage II and 3,722 with stages III and IV lung cancer, with 75% of stage I and 68.3% of stage II undergoing PET-CT. PET-CT has become more common over time. Patients aged 80 years and over, Māori, those with frailty (ECOG 2+), and those with stages II-IV of disease were less likely to receive PET-CT. Gender, socio-economic status and comorbidities did not influence the use of PET-CT. CONCLUSION: PET-CT is a standard of care for patients with early-stage lung cancer, suitable for curative treatment. The disparity of access to PET-CT for Māori needs to be addressed.
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W7233714010
FWCI:
Cites: 19
Cited by:
Related to: 10